|
|
![]() | ![]() | ![]() | ![]() |
Amsurg 8-K 2010 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2010 (April 8, 2010)
AMSURG CORP.
(Exact Name of Registrant as Specified in Charter)
(615) 665-1283
(Registrants Telephone Number, Including Area Code) Not Applicable
(Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure
On April 8, 2010, AmSurg Corp. issued a press release, the text of which is set forth as
Exhibit 99.
Item 9.01. Financial Statements and Exhibits
(c) 99 Press release dated April 8, 2010
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 9, 2010
3
INDEX TO EXHIBITS
4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||